STOCK TITAN
  1. Home
  2. Sec-filings
  3. CRWV
  4. [144] CoreWeave, Inc. SEC Filing

CRWV (CRWV) holder files to sell 25,000 shares and discloses 10b5-1 trades

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

A stockholder of CRWV filed to sell 25,000 shares of common stock through Morgan Stanley Smith Barney LLC Executive Financial Services, with an aggregate market value of $2,266,750.00 as of NASDAQ pricing on 08/10/2026. The shares are identified as Founders Shares originally acquired on 02/25/2019. The filing also lists extensive Rule 10b5-1 plan sales over the past three months by Brannin McBee, Meghan Bennett, and several related trusts, including multiple block sales of common stock on various dates in June, July, and early August 2026 with individual transactions as large as 144,000 shares.

Positive

  • None.

Negative

  • None.
Planned shares to be sold 25,000 shares Common stock proposed for sale through Morgan Stanley Smith Barney LLC
Aggregate market value of planned sale $2,266,750.00 Market value of 25,000 shares as of NASDAQ pricing on 08/10/2026
Security identifier 447573939 Identifier associated with the CRWV common stock being sold
10b5-1 sale by Brannin McBee on 08/03/2026 144,000 shares; $11,860,963.20 Common stock sold under a Rule 10b5-1 plan
10b5-1 sale by Meghan Bennett on 08/03/2026 25,000 shares; $2,059,195.00 Common stock sold under a Rule 10b5-1 plan
10b5-1 sale by CANIS MAJOR 2025 GRAT on 06/22/2026 40,000 shares; $4,451,020.00 Common stock sold under a Rule 10b5-1 plan
Direct sale by Brannin McBee on 05/20/2026 3,683 shares; $367,637.06 Common stock sale outside the grouped 10b5-1 entries
Form 144 regulatory
"144: Securities Information Common | Morgan Stanley Smith Barney LLC"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
Founders Shares financial
"Common | 02/25/2019 | Founders Shares | Issuer"
Founders shares are a special block of a company’s stock originally given to the people who started the business; they often carry extra voting power or favorable terms compared with regular shares. For investors, these shares matter because they concentrate control and influence how future funding, ownership dilution, and decision-making will play out—think of founders shares as the steering wheel that can steer a company’s direction even as more passengers (investors) climb aboard.
Rule 10b5-1 regulatory
"10b5-1 Sales for BRANNIN MCBEE 290 W Mt. Pleasant Ave."
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.
irrevocable trust financial
"CANIS MAJOR 2024 IRREVOCABLE TR LLC 290 W Mt. Pleasant Ave."
An irrevocable trust is a legal arrangement where an owner transfers assets into a separate entity managed by a trustee and gives up the power to modify or reclaim those assets. For investors it matters because putting stock or other holdings into such a trust can change who controls and benefits from the assets, affect taxes and creditor protection, and influence how easy it is to sell or value those holdings—like placing valuables in a locked safe overseen by someone else.
GRAT financial
"CANIS MAJOR 2025 GRAT 290 W Mt. Pleasant Ave."
Executive Financial Services financial
"Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

FAQ

What stock sale is being planned for CRWV in this Form 144 filing?
A CRWV stockholder plans to sell 25,000 common shares with an aggregate value of $2,266,750.00, using Morgan Stanley Smith Barney LLC Executive Financial Services as broker, based on NASDAQ pricing as of 08/10/2026.

Who is the broker handling the planned CRWV share sale?
The planned CRWV sale will be executed through Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004, according to the Form 144 disclosure.

What type of CRWV shares are being proposed for sale and when were they acquired?
The proposed sale involves Founders Shares of CRWV common stock. The Form 144 indicates these shares were originally acquired on 02/25/2019, and 25,000 of those shares are now proposed for resale.

What recent 10b5-1 sales involving CRWV stock are disclosed?
The filing lists multiple Rule 10b5-1 plan sales of CRWV common stock in June–August 2026 by Brannin McBee, Meghan Bennett, and related trusts, including individual transactions of 144,000 shares on several trading dates.

What is the largest individual CRWV transaction reported in the past three months?
Among the reported transactions, Brannin McBee executed several 144,000-share sales of CRWV common stock under 10b5-1 plans, with individual proceeds such as $11,860,963.20 on 08/03/2026 and similar-sized trades on earlier June and July dates.

Are trusts associated with insiders also selling CRWV shares under 10b5-1 plans?
Yes. The disclosure includes 10b5-1 sales for entities such as CANIS MAJOR 2024 IRREVOCABLE TR LLC, CANIS MAJOR 2025 GRAT, and BRANNIN J. MCBEE 2022 IRR TRUST, each reporting CRWV common stock sales on multiple June–August 2026 dates.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Source: View Original Filing on SEC EDGAR